Publications

5674 Results

Prognostic Value of Interim FDG-PET in Diffuse Large Cell Lymphoma: Results From the CALGB 50303 Clinical Trial

Authors
H Schoder;M Polley;M Knopp;N Hall;L Kostakoglu;J Zhang;H Higley;G Kelloff;H Liu;A Zelenetz;B Cheson;N Wagner-Johnston;B Kahl;J Friedberg;E Hsi;JP Leonard;L Schwartz;W Wilson;N Bartlett
Journal / Conference
Blood Jun 18;135(25):2224-2234; Mar 13;blood.2019003277. doi: 10.1182/blood.2019003277. Online ahead of print.
Year
2020
Research Committee(s)
Lymphoma
PMID
PMID32232481
PMC
PMC7316220

A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer

Authors
J Zhong;A Jermusyk;I Collins;E Mocci;M Zhang;L Song;D Albanes;C Fuchs;J Gaziano;G Goodman;P Goodman;E Klein;G Petersen;W Zheng;L Amundadottir
Journal / Conference
Journal of the Natlonal Cancer Institute Oct 1;112(10):1003-1012; Jan 9; doi: 10.1093/jnci/djz246. [Epub ahead of print]
Year
2020
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID31917448
Study Number(s)
S0000

Association of Patient Demographic Characteristics and Insurance Status with Survival in Cancer Randomized Clinical Trials with Positive Findings

Authors
JM Unger;CD Blanke;M Leblanc;W Barlow;R Vaidya;M Fleury;SD Ramsey;DL Hershman
Journal / Conference
JAMA Network Open Apr 1;3(4):e203842
Year
2020
Research Committee(s)
Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lung, Lymphoma, and Myeloma
PMID
PMID32352530
PMC
PMC7193331
Study Number(s)
S0200, S0777, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8591(NCI Intergroup #0035), SWOG-8624, SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8736 (INT-0093), SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-8814, SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817), SWOG-8897, SWOG-8949, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9126, SWOG-9210, SWOG-9308, S9916

Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials

Authors
D Hershman;C Till;J Wright;M Accordino;R Vaidya;W Barlow;S Ramsey;J Unger
Journal / Conference
Breast Cancer Research and Treatment Jun;181(2):455-463
Year
2020
Research Committee(s)
Breast and Cancer Care Delivery
PMID
PMID32306168
PMC
PMC8218818
Study Number(s)
S0012, S0221, S0226, S0307, S0500

Randomized Trial of Text-Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer: SWOG S1105

Authors
DL Hershman;JM Unger;G Clarke Hillyer;A Moseley;K Arnold;S Dakhil;B Esparaz;M Kuan;ML Graham;D Lackowski;W Edenfield;Z Dayao;NL Henry;J Gralow;S Ramsey;A Neugut
Journal / Conference
Journal of Clinical Oncology Jul 1;38(19):2122-2129; May 5;JCO1902699. doi: 10.1200/JCO.19.02699. Online ahead of print.
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID32369401
PMC
PMC7325363
Study Number(s)
S1105

Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration

Authors
A Sobrero;T Andre;J Meyerhardt;A Grothey;T Iveson;T Yoshino;I Souglakos;J Meyers;R Labianca;M Saunders;D Vernerey;T Yamanaka;I Boukovinas;E Georgoulias;V Torri;A Harkin;J Taieb;A Shields;Q Shi
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 4004); American Society of Clinical Oncology 2020 Annual Meeting, oral
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study)

Authors
N Leighl;M Redman;N Rizvi;F Hirsch;P Mack;L Schwartz;J Wade;W Irvin;S Reddy;J Crawford;J Bradley;T Stinchcombe;S Ramalingam;J Miao;K Minichiello;D Gandara;RS Herbst;V Papadimitrakopoulou;K Kelly
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 9623); American Society of Clinical Oncology Annual Meeting (5/29/2020 - 6/2/2020, Chicago, IL), poster session
Year
2020
Research Committee(s)
Lung
Study Number(s)
S1400F

SWOG S1505: Results of Perioperative Chemotherapy with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Authors
D Sohal;M Duong;S Ahmad;N Gandhi;MS Beg;A Wang-Gillam;JL Wade, III;E Chiorean;K Guthrie;A Lowy;PA Philip;H Hochster
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 4504); American Society of Clinical Oncology Annual Meeting (5/29/2020 - 6/2/2020, Chicago, IL), oral
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Metaplastic Carcinoma of the Breast: DART (SWOG S1609, Cohort 36)

Authors
S Adams;M Othus;S Patel;Y Chae;K Miller;R Chugh;S Schuetze;E Sharon;L Korde;R Gray;E Mayerson;M Plets;R Kurzrock
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 1073); American Society of Clinical Oncology 2020 Annual Meeting, poster session
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416)

Authors
P Sharma;E Rodler;W Barlow;J Gralow;S Puhalla;C Anders;L Goldstein;U Brown-Glaberman;T-T Huynk;C Szyarto;A Godwin;H Pathak;E Swisher;M Radke;K Timms;D Lew;J Miao;L Pusztai;D Hayes;G Hortobagyi
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 1001); American Society of Clinical Oncology 2020 Annual Meeting, oral
Year
2020
Research Committee(s)
Breast
Study Number(s)
S1416